<DOC>
	<DOCNO>NCT00782197</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety PRGF infiltration treatment knee osteoarthritis .</brief_summary>
	<brief_title>Autologous Plasma Rich Growth Factors ( PRGF ) Treating Symptomatic Knee OA</brief_title>
	<detailed_description>Several study show positive effect autologous `` Preparation Rich Growth Factors '' ( PRGF ) different clinical situation involve connective tissue also OA synovial cell . PRGF biological delivery system complex mixture bioactive proteins essential natural repair include anabolic factor cartilage transform growth factor-β1 ( TGF-β1 ) , platelet-derived growth factor ( PDGF ) insulin-like growth factor ( IGF-I ) . The potential PRGF enhance limit capacity cartilage repair encourage idea treat degenerative joint condition autologous preparation . The present study undertaken ass efficacy safety intra-articular injection PRGF obtain useful information clinical effect . Since pain pressing problem face people OA , significant improvement pain would indicate potential propose treatment . We also evaluate functionality quality life . In addition examine change novel serum synovial fluid biomarkers correlation MRI-based parameter subgroup patient .</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Patients sex age 40 72 year . Diagnosed osteoarthritis knee radiological image . Pain joint equal great 2.5 point EAV . Radiological severity : Value Ahlback score 3 less . Body mass index 20 30 . Possibility observation followup period . Bilateral Gonarthrosis require infiltration knee . Body mass index great 30 . Diagnosed polyarticular disease . Severe mechanical deformation . Previous arthroscopy past year . Intraarticular infiltration hyaluronic acid last 6 month . Rheumatic autoimmune systemic disease . Poorly control diabetes mellitus . Blood alteration . Immunosuppressive treatment and/or coumarinics . Treatment steroids 3 month prior inclusion study . Treatment nonsteroidal antiinflammatory drug 15 day prior inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
	<keyword>PRGF</keyword>
	<keyword>autologous plasma</keyword>
	<keyword>plasma preparation</keyword>
	<keyword>treatment</keyword>
</DOC>